[1]刘彬彬、卢玉昭,岳建人、曹成龙、马 盼,徐国政、宋 健.长期接受抗凝抗聚药物治疗病人并发脑出血的治疗分析[J].临床神经外科杂志,2019,16(04):416-418.[doi:10.13798/j.issn.1009-153X.2019.07.011]
 LIU Bin-bin,LU Yu-zhao,YUE Jian-ren,et al.Treatment of long-term anticoagulation and antiaggregation-related cerebral hemorrhage: single center experience in 33 cases[J].Journal of Clinical Neurosurgery,2019,16(04):416-418.[doi:10.13798/j.issn.1009-153X.2019.07.011]
点击复制

长期接受抗凝抗聚药物治疗病人并发脑出血的治疗分析 ()
分享到:

《临床神经外科杂志》[ISSN:1672-7770/CN:32-1727/R]

卷:
16
期数:
2019年04期
页码:
416-418
栏目:
论著
出版日期:
2019-08-15

文章信息/Info

Title:
Treatment of long-term anticoagulation and antiaggregation-related cerebral hemorrhage: single center experience in 33 cases
文章编号:
10.13798/j.issn.1009-153X.2019.07.011
作者:
刘彬彬、卢玉昭;岳建人、曹成龙、马 盼;徐国政、宋 健
430065 武汉,武汉科技大学医学院(刘彬彬、卢玉昭);510515 广州,南方医科大学研究生院(岳建人、曹成龙、马 盼);430070 武汉,中国人民解放军中部战区总医院神经外科(徐国政、宋 健)
Author(s):
LIU Bin-bin1 LU Yu-zhao1 YUE Jian-ren2 CAO Cheng-long2 MA Pan2 XU Guo-zheng3 SONG jian3. 1. Medical School Wuhan University of Sciences and Technology Wuhan 430070 China; 2. Graduate School Nanfang Medical University Guangzhou 510515 China; 3. Department of Neurosurgery General Hospital Central Theater PLA Wuhan 430070 China
1. Medical School, Wuhan University of Sciences and Technology, Wuhan 430070, China; 2. Graduate School, Nanfang Medical University, Guangzhou 510515, China; 3. Department of Neurosurgery, General Hospital, Central Theater, PLA, Wuhan 430070, China
关键词:
脑出血凝血功能抗凝药物抗聚药物治疗
Keywords:
Anticoagulation Antiaggregation Cerebral hemorrhage Treatment
分类号:
R 743.34; R 651.1+2
DOI:
10.13798/j.issn.1009-153X.2019.07.011
文献标志码:
A
摘要:
目的 探讨长期接受抗凝抗聚药物治疗病人发生脑出血的治疗方法及疗效。方法 回顾性分析2014年8月至2018年8月收治的33例长期接受抗凝抗聚药物治疗的脑出血的临床资料。保守治疗10例,急诊开颅血肿清除+去骨瓣减压术7例,钻孔引流术16例。结果 术后死亡1例(3%)。32例平均随访6个月,依据日常生活能力量表:Ⅰ级2例,Ⅱ级11例,Ⅲ级12例,Ⅳ级5例,Ⅴ级2例。结论 对长期接受抗凝抗聚药物治疗的脑出血,应密切监测凝血功能及相关指标参数,根据病人的具体情况选择针对性的治疗措施。
Abstract:
Objective To summarize the clinical experience in treating the cerebral hemorrhage in patients who received long-term anticoagulation and antiaggregation therapy (LTAAT). Methods The clinical data of 33 consecutive patients with cerebral hemorrhage receiving LTAAT, who were treated in Department of Neurosurgery of General Hospital of Central Theater from August, 2014 to August, 2018, were analyzed retrospectively. Of these 33 patients, 10 were conservatively treated, 7 by removal of intracranial hematomas and skull bone flaps and 16 by skull drilling and drainage of intracranial hematomas. Results Of these 33 patients, 1 (3.0%) died, 2 (6.1%) belonged in the activities of daily living grade I, 11 (33.3%) in grade Ⅱ, 12 (36.4%) in grade Ⅲ, 5 (15.2%) in grade Ⅳ, and 2 (6.1%) in grade V. Conclusions The coagulation function and related indicators and parameters should be closely monitored in the patients with cerebral hemorrhage who have received LTAAT, and the methods directing against their specific conditions should are selected.

参考文献/References:

[1] 朱 勇,吕中华,陈 江. 软通道治疗抗凝或抗栓药物相 关性脑出血21例临床分析[J]. 浙江创伤外科,2018,23 (1):120-122. [2] 印辰宇,马建华,季海明. 抗凝药物相关脑出血病人开颅 手术前处理策略[J]. 海峡药学,2015,27(11):173-174. [3] 周玉利,周青雪,赵洪灿. 血栓弹力图应用于冠心病心律 不齐型的凝血监测[J]. 现代实用医学,2015,27(4): 427-428. [4] De Pietri L, Bianchini M, Montalti R, et al. Thrombelasto- graphy-guided blood product use before invasive proce- dures in cirrhosis with severe coagulopathy: a randomized, controlled trial [J]. Hepatology, 2016, 63(2): 566-573. [5] Schulman S, Gross PL, Ritchie B, et al. Prothrombin com- plex concentrate for major bleeding on factor xa inhibitors: a prospective cohort study [J]. Thromb Haemost, 2018, 118 (5): 842-851. [6] 黄 璠. 人凝血酶原复合物的制备及临床应用[J]. 临床医 药实践,2014,23(7):529-532. [7] Abdoellakhan RA, Miah IP, Khorsand N, et al. Fixed versus variable dosing of prothrombin complex concentrate in vitamin K antagonist-related intracranial hemorrhage: a retrospective analysis [J]. Neurocrit Care, 2017, 26(1): 64- 69. [8] Steiner T, Poli S, Griebe M, et al. Fresh frozen plasma versus prothrombin complex concentrate in patients with intracra- nial haemorrhage related to vitamin K antagonists (INCH): a randomised trial [J]. Lancet Neurol, 2016, 15(6): 566-573. [9] 王广杰,金 娴,曹廷卉,等. 输注新鲜冰冻血浆病人血液 相关指标变化与疗效分析[J]. 检验医学与临床,2016,13 (22):3214-3216. [10] 王建涛,阚志生. 华法林相关脑出血的临床特点及手术疗 效(附65例报告)[J]. 中华神经外科杂志,2017,33(2): 164-168.

相似文献/References:

[1]彭爱军,蒋京功,周肖东,等.汉语失语症测评软件在脑出血失语评定中的临床应用[J].临床神经外科杂志,2014,(01):58.
[2]陈军,李爱民,陈震.脑血流重建术治疗出血型烟雾病[J].临床神经外科杂志,2016,(01):21.
[3]刘永,张玉海,何升学,等.经外侧裂岛叶入显微清除高血压性基底节区脑出血[J].临床神经外科杂志,2015,(05):375.
[4]周杰,马建荣,谷欣.APACHE IV评分评估重症颅脑外伤的预后价值[J].临床神经外科杂志,2015,(06):426.
[5]蔡可胜.血肿及脑室穿刺外引流治疗高血压脑出血89例临床分析[J].临床神经外科杂志,2014,(02):145.
[6]徐德才,张少军,娄飞云.骨髓间充质干细胞移植治疗脑出血大鼠的实验研究[J].临床神经外科杂志,2014,(03):200.
[7]张宏兵,王晓峰,唐宗椿,等.颅内压监测在高血压脑出血置管引流治疗中的应用[J].临床神经外科杂志,2014,(03):219.
[8]邢涛,付志辉,张荣俊,等.高血压脑出血患者偏瘫相关弥散张量成像研究[J].临床神经外科杂志,2014,(04):255.
[9]郝璞珩,李娜,金林.血清Tau蛋白水平与脑出血患者早期预后的相关性分析[J].临床神经外科杂志,2014,(06):453.
[10]张梨,袁贤瑞.轻中度颅脑损伤后凝血功能变化与手术预测的关系[J].临床神经外科杂志,2016,(05):374.
 ZHANG Li,YUAN Xian-rui..Correlation of coagulation changesand surgical predicted of mild to moderate traumatic brain injury[J].Journal of Clinical Neurosurgery,2016,(04):374.

备注/Memo

备注/Memo:
(2019-03-04收稿,2019-03-18修回)基金项目:国家自然科学基金(81571049;81400865) 通讯作者:宋 健,E-mail:sn413314@126.com
更新日期/Last Update: 1900-01-01